[{"NetIncomeLoss_2_Q2_USD":-44023000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":9.9,"GeneralAndAdministrativeExpense_2_Q2_USD":9516000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4990000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":34779647.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":34814631.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfSharesRestrictedStock_2_Q2_shares":16367.0,"WeightedAverageNumberOfSharesRestrictedStock_1_Q2_shares":8963.0,"OperatingCostsAndExpenses_2_Q2_USD":44094000.0,"OperatingCostsAndExpenses_1_Q2_USD":28966000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-9000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":47630000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":8346000.0,"Depreciation_2_Q2_USD":21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":318063.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":331000.0,"AssetsCurrent_0_Q2_USD":236222000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3966208.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":393000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":2436000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":321000.0,"CommonStockSharesIssued_0_Q2_shares":34840782.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q2_USD":6662000.0,"Assets_0_Q2_USD":238009000.0,"MarketableSecuritiesCurrent_0_Q2_USD":72490000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":13.47,"OperatingLeaseLiability_0_Q2_USD":1610000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":473688000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":34578000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":23976000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.47,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2017000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":4475000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.7043,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.7043,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":4000.0,"OtherNonoperatingIncome_2_Q2_USD":71000.0,"OtherNonoperatingIncome_1_Q2_USD":33000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q2_USD":9000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":290000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":342000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":230028000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-44029000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-28940000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1121000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0105,"OtherAssetsNoncurrent_0_Q2_USD":115000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":157538000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1417000.0,"Liabilities_0_Q2_USD":17876000.0,"ShareBasedCompensation_2_Q2_USD":4800000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1562000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LeaseCost_1_Q2_USD":81000.0,"MarketableSecurities_0_Q2_USD":223869000.0,"CommonStockSharesOutstanding_0_Q2_shares":34840782.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":31654000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3962372.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":-6000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":-7000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38380000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":312000.0,"LiabilitiesCurrent_0_Q2_USD":16459000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-29744000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":47630000.0,"AccountsPayableCurrent_0_Q2_USD":2307000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":157646000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6194000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":417000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.076,"CashEquivalentsAtCarryingValue_0_Q2_USD":151379000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":89003.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":215000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":150000.0,"OperatingLeasePayments_1_Q2_USD":75000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":23967000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":110000.0,"NetIncomeLoss_1_Q2_USD":-28933000.0,"LeaseCost_2_Q2_USD":162000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-253550000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_2_Q2_USD":9000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1585509.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":16.27,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":16.49,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":407000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":341000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2848000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_2_Q2_USD":-44094000.0,"OperatingIncomeLoss_1_Q2_USD":-28966000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":13042767.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":223878000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":223869000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":153000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.69,"LiabilitiesAndStockholdersEquity_0_Q2_USD":238009000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1594000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4800000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2436000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":23595000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":193000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.83,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.27,"ProfitLoss_2_Q2_USD":-44023000.0,"StockholdersEquity_0_Q2_USD":220133000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-303000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3962372.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":26.47,"AccruedProfessionalFeesCurrent_0_Q2_USD":76000.0,"Ticker":"AKRO","CIK":"1744659","name":"AKERO THERAPEUTICS, INC.","OfficialName":"Akero Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"399847718.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210813"}]